Pancreatic NET (PNET)

PRRT Trials

• Alpha PRRT with Pb212 (all NET)

• Alpha PRRT with Ac225 (GEPNETs only)

• Lu177 DOTATATE + M3814 (Peposertib)  (GEPNETs)

• Lu177 DOTATATE + Olaparib  (GEPNETs)

• Lu177 DOTATATE + Triapine (GEPNETs)

• Lu177 DOTATATE + Cabozantanib (all NET)

• COMPOSE (GEPNETS)

• ComPareNET Lu177 vs CAPTEM in PNETs

• Lu-177 DOTATATE vs Everolimus in Lung NETs

• NETTER-P: Lutathera in Adolescent Patients 

Oral Treatment

• CABINET: Cabozantinib in Advanced pNET and Carcinoid Tumors

• SWOG S2104: Adjuvant CAPTEM for High Risk pNET

• Belzutifan/MK-6482  in PNET + PPGL + VHL

• CDK4/6 Abemaciclib

Other Trials

• SORRENTO: Subcutaneous Octreotide for GEPNETs

• Surviving Long Peptide Vaccine (SurVaxM) in Metastatic NETs